Nuzenio

First Pivotal Cohort

First Pivotal Cohort news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Kodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026 - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 11:00:00 GMTBeam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD) - marketscreener.commarketscreener.com · Tue, 04 Aug 2026 11:00:06 GMTBeam Therapeutics doses first patient in BEAM-3... - PluangPluang · Tue, 04 Aug 2026 07:00:00 GMTTScan Therapeutics doses first patient in pivotal Phase 3 ALLOHA-2 trial of TSC-101 - DealroomDealroom · Thu, 30 Jul 2026 09:06:02 GMTTScan Therapeutics Announces First Patient Dosed in Phase 3 - GlobeNewswireGlobeNewswire · Wed, 29 Jul 2026 11:00:00 GMT

Timeline

Thu, 06 Aug 2026 11:00:00 GMTKodiak Sciences Completes Enrollment in First Pivotal Cohort in the Phase 3 PEAK Trial of KSI-101 for Macular Edema Secondary to Inflammation and Reaffirms Topline Clinical Data Release Remains on Track for December 2026 - Yahoo Finance
Tue, 04 Aug 2026 11:00:06 GMTBeam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD) - marketscreener.com
Tue, 04 Aug 2026 07:00:00 GMTBeam Therapeutics doses first patient in BEAM-3... - Pluang
Thu, 30 Jul 2026 09:06:02 GMTTScan Therapeutics doses first patient in pivotal Phase 3 ALLOHA-2 trial of TSC-101 - Dealroom
Wed, 29 Jul 2026 11:00:00 GMTTScan Therapeutics Announces First Patient Dosed in Phase 3 - GlobeNewswire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for First Pivotal Cohort.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.